Kimberly-Clark Corporation (KMB) stock rose 1.4% following the company's presentation at the 2026 Consumer Analyst Group of New York Conference on February 19, 2026. During the presentation, the company outlined its "Powering Care" transformation strategy and discussed its pending acquisition of Kenvue. CEO Mike Hsu highlighted that the company has delivered volume-plus-mix led growth since launching Powering Care in 2024, with market share gains in two-thirds of its country and category combinations over the past two years. The company reported achieving gross productivity in the 6% range of cost of goods sold for the past two years. Kimberly-Clark and Kenvue shareholders had overwhelmingly approved the acquisition on January 29, 2026, with approximately 96% of Kimberly-Clark shares voting in favor. The transaction is expected to close in the second half of 2026.
Read full analysisKimberly-Clark Corporation (KMB) stock rose 1.4% following the company's presentation at the 2026 Consumer Analyst Group of New York Conference on February 19, 2026. During the presentation, the company outlined its "Powering Care" transformation strategy and discussed its pending acquisition of Kenvue. CEO Mike Hsu highlighted that the company has delivered volume-plus-mix led growth since launching Powering Care in 2024, with market share gains in two-thirds of its country and category combinations over the past two years. The company reported achieving gross productivity in the 6% range of cost of goods sold for the past two years. Kimberly-Clark and Kenvue shareholders had overwhelmingly approved the acquisition on January 29, 2026, with approximately 96% of Kimberly-Clark shares voting in favor. The transaction is expected to close in the second half of 2026.
Kimberly-Clark is a global consumer products company known for household brands like Huggies, Kleenex, and Scott, operating across personal care and tissue segments. The company is pursuing a transformative acquisition of Kenvue, the consumer health spinoff from Johnson & Johnson, with the deal overwhelmingly approved by shareholders and expected to close in the second half of 2026. Today's move reflects its role as a defensive staples name benefiting from rotation out of risk assets.